Payment overview · 2025
General Payments
$0.39
1 reported records · 1 companies
Healthcare provider profile · identity verified
Candice Dean, DO
Allopathic & Osteopathic Physicians|Internal Medicine · LONGVIEW, TX · NPI 1174878540
Verified facts
What the public records show
CMS Open Payments records show Candice Dean, DO received $0.39 in general payments during 2025 across 1 reported records.
Travere Therapeutics, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Travere Therapeutics, Inc. | Unresolved — no canonical attribution shown | $0.39 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $0.39 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Filspari Normalized: filspari |
Drug | Travere Therapeutics, Inc. | $0.39 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 969 | 269 |
| Losartan Potassium | Losartan Potassium | 782 | 219 |
| Levothyroxine Sodium | Levothyroxine Sodium | 776 | 192 |
| Pantoprazole Sodium | Pantoprazole Sodium | 745 | 221 |
| Gabapentin | Gabapentin | 680 | 189 |
| Amlodipine Besylate | Amlodipine Besylate | 661 | 187 |
| Potassium Chloride | Potassium Chloride | 576 | 175 |
| Tizanidine Hcl | Tizanidine Hcl | 454 | 141 |
| Lisinopril | Lisinopril | 443 | 123 |
| Hydrochlorothiazide | Hydrochlorothiazide | 432 | 124 |
| Simvastatin | Simvastatin | 431 | 112 |
| Trazodone Hcl | Trazodone Hcl | 418 | 123 |
| Metformin Hcl | Metformin Hcl | 407 | 118 |
| Fluticasone Propionate | Fluticasone Propionate | 356 | 141 |
| Montelukast Sodium | Montelukast Sodium | 346 | 103 |
| Omeprazole | Omeprazole | 346 | 87 |
| Carvedilol | Carvedilol | 338 | 103 |
| Duloxetine Hcl | Duloxetine Hcl | 313 | 86 |
| Tramadol Hcl | Tramadol Hcl | 309 | 84 |
| Furosemide | Furosemide | 304 | 96 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 266 | 89 |
| Metoprolol Succinate | Metoprolol Succinate | 232 | 73 |
| Glimepiride | Glimepiride | 225 | 65 |
| Buspirone Hcl | Buspirone Hcl | 223 | 70 |
| Meloxicam | Meloxicam | 207 | 63 |
| Escitalopram Oxalate | Escitalopram Oxalate | 199 | 55 |
| Clopidogrel | Clopidogrel Bisulfate | 196 | 56 |
| Tamsulosin Hcl | Tamsulosin Hcl | 190 | 50 |
| Mirtazapine | Mirtazapine | 167 | 48 |
| Famotidine | Famotidine | 165 | 60 |
| Allopurinol | Allopurinol | 162 | 43 |
| Sertraline Hcl | Sertraline Hcl | 162 | 36 |
| Bupropion Xl | Bupropion Hcl | 152 | 46 |
| Celecoxib | Celecoxib | 152 | 46 |
| Metoprolol Tartrate | Metoprolol Tartrate | 151 | 42 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 142 | 48 |
| Pravastatin Sodium | Pravastatin Sodium | 141 | 43 |
| Prednisone | Prednisone | 137 | 107 |
| Jardiance | Empagliflozin | 135 | 38 |
| Donepezil Hcl | Donepezil Hcl | 134 | 43 |
| Mounjaro | Tirzepatide | 129 | 19 |
| Diclofenac Sodium | Diclofenac Sodium | 128 | 42 |
| Amitriptyline Hcl | Amitriptyline Hcl | 124 | 29 |
| Citalopram Hbr | Citalopram Hydrobromide | 124 | 38 |
| Nifedipine Er | Nifedipine | 123 | 36 |
| Clonazepam | Clonazepam | 120 | 22 |
| Ozempic | Semaglutide | 114 | 20 |
| Methocarbamol | Methocarbamol | 111 | 37 |
| Pregabalin | Pregabalin | 109 | 27 |
| Spironolactone | Spironolactone | 106 | 34 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 102 | 31 |
| Pioglitazone Hcl | Pioglitazone Hcl | 102 | 26 |
| Alendronate Sodium | Alendronate Sodium | 96 | 31 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 96 | 28 |
| Eliquis | Apixaban | 93 | 30 |
| Ondansetron Hcl | Ondansetron Hcl | 90 | 46 |
| Hydralazine Hcl | Hydralazine Hcl | 88 | 31 |
| Synthroid | Levothyroxine Sodium | 88 | 25 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 78 | 23 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 76 | 18 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 76 | 22 |
| Zolpidem Tartrate | Zolpidem Tartrate | 76 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 74 | 18 |
| Alprazolam | Alprazolam | 72 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 72 | 20 |
| Levofloxacin | Levofloxacin | 69 | 52 |
| Ondansetron Odt | Ondansetron | 69 | 19 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 68 | 44 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 67 | 18 |
| Gemfibrozil | Gemfibrozil | 67 | 20 |
| Temazepam | Temazepam | 67 | 12 |
| Finasteride | Finasteride | 66 | 17 |
| Warfarin Sodium | Warfarin Sodium | 65 | 28 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 64 | 56 |
| Nystatin | Nystatin | 63 | 37 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 63 | 17 |
| Dicyclomine Hcl | Dicyclomine Hcl | 62 | 28 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 62 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 62 | 18 |
| Cefuroxime | Cefuroxime Axetil | 61 | 48 |
| Atenolol | Atenolol | 60 | 13 |
| Fenofibrate | Fenofibrate Nanocrystallized | 59 | 18 |
| Quetiapine Fumarate | Quetiapine Fumarate | 58 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 57 | 24 |
| Glipizide | Glipizide | 56 | 16 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 55 | 14 |
| Azithromycin | Azithromycin | 54 | 51 |
| Klor-Con M20 | Potassium Chloride | 52 | 17 |
| Memantine Hcl | Memantine Hcl | 52 | 11 |
| Mupirocin | Mupirocin | 51 | 31 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 51 | 14 |
| Ezetimibe | Ezetimibe | 50 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 50 | 18 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 50 | 22 |
| Sumatriptan Succinate | Sumatriptan Succinate | 50 | 19 |
| Oxybutynin Chloride | Oxybutynin Chloride | 49 | 11 |
| Tradjenta | Linagliptin | 48 | 13 |
| Metformin Hcl Er | Metformin Hcl | 47 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 46 | 36 |
| Valacyclovir | Valacyclovir Hcl | 46 | 20 |
| Paroxetine Hcl | Paroxetine Hcl | 45 | 13 |
| Testosterone Cypionate | Testosterone Cypionate | 45 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 44 | 13 |
| Estradiol | Estradiol | 43 | 21 |
| Clonidine Hcl | Clonidine Hcl | 42 | 17 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 42 | 11 |
| Levetiracetam | Levetiracetam | 42 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 40 | 13 |
| Chlorthalidone | Chlorthalidone | 40 | 16 |
| Symbicort | Budesonide/Formoterol Fumarate | 40 | 12 |
| Trulicity | Dulaglutide | 39 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 38 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 38 | suppressed |
| Januvia | Sitagliptin Phosphate | 37 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 35 | suppressed |
| Topiramate | Topiramate | 35 | suppressed |
| Irbesartan | Irbesartan | 34 | suppressed |
| Fluconazole | Fluconazole | 32 | 27 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 32 | suppressed |
| Cephalexin | Cephalexin | 31 | 22 |
| Aripiprazole | Aripiprazole | 30 | suppressed |
| Xarelto | Rivaroxaban | 30 | suppressed |
| Acyclovir | Acyclovir | 29 | 13 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 29 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 29 | 20 |
| Valsartan | Valsartan | 29 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 29 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | 11 |
| Lactulose | Lactulose | 28 | suppressed |
| Myrbetriq | Mirabegron | 28 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 28 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 27 | 14 |
| Fenofibrate | Fenofibrate | 27 | suppressed |
| Torsemide | Torsemide | 27 | suppressed |
| Verapamil Er | Verapamil Hcl | 26 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 25 | suppressed |
| Lorazepam | Lorazepam | 25 | 14 |
| Novolog Flexpen | Insulin Aspart | 24 | suppressed |
| Linzess | Linaclotide | 23 | 11 |
| Telmisartan | Telmisartan | 23 | suppressed |
| Lidocaine | Lidocaine | 22 | suppressed |
| Lovastatin | Lovastatin | 22 | suppressed |
| Nabumetone | Nabumetone | 22 | suppressed |
| Nitroglycerin | Nitroglycerin | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Hydrocortisone | Hydrocortisone | 21 | suppressed |
| Ibuprofen | Ibuprofen | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 21 | suppressed |
| Humalog | Insulin Lispro | 20 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 20 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 20 | 18 |
| Propranolol Hcl | Propranolol Hcl | 20 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 19 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 19 | 19 |
| Glipizide Er | Glipizide | 19 | suppressed |
| Ketoconazole | Ketoconazole | 19 | suppressed |
| Novolog | Insulin Aspart | 19 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 19 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 19 | 11 |
| Azelastine Hcl | Azelastine Hcl | 18 | 12 |
| Paxlovid | Nirmatrelvir/Ritonavir | 18 | 18 |
| Verapamil Hcl | Verapamil Hcl | 18 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 17 | 11 |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 17 | suppressed |
| Nystop | Nystatin | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 16 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 16 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 16 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Glyburide | Glyburide | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Cilostazol | Cilostazol | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Erythromycin | Erythromycin Base | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $0.39 · 1 records | Travere Therapeutics, Inc. | Filspari | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error